Pharmaceutical formulations for the sustained release of interferons and therapeutic applications thereof

Details for Australian Patent Application No. 2004292370

Owner Details removed by request.

Inventors Details removed by request.

Agent Details removed by request.

Pub. Number AU-B-2004292370

PCT Pub. Number WO2005/051417

Priority 0350886 21.11.03 FR

Filing date 19 November 2004

Wipo publication date 9 June 2005

Acceptance publication date 2 December 2010

International Classifications

A61K 9/10 (2006.01) Medicinal preparations characterised by special physical form - Dispersions

A61K 9/14 (2006.01) Medicinal preparations characterised by special physical form - Particulate form, e.g. powders

A61K 38/20 (2006.01) Medicinal preparations containing peptides - Interleukins

A61K 38/21 (2006.01) Medicinal preparations containing peptides - Interferons

A61K 47/42 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Proteins

A61K 47/48 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates

Event Publications

13 July 2006 PCT application entered the National Phase

2 December 2010 Application Accepted

31 March 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004292371-Pharmaceutical formulations for the sustained release of interleukins and therapeutic applications thereof

2004292369-Pharmaceutical formulations for the sustained release of one or more active principles and applications thereof, such as therapeutic applications